HCMV (AD169 Strain) Quantitated Viral DNA
产品名称: HCMV (AD169 Strain) Quantitated Viral DNA
英文名称: HCMV (AD169 Strain) Quantitated Viral DNA
产品编号: HCMV (AD169 Strain) Quantitated Viral DNA
产品价格: 0
产品产地: 美国
品牌商标:
更新时间: 2023-09-19T20:47:01
使用范围: null
详情请登录:www.biologcs.com/product-show-264.html
Description(名称) | HCMV (AD169 Strain) Quantitated Viral DNA |
Catalog #(货号) | 08-925-000 |
Size(规格) | 250 µL |
Price(价格) | 请联系:0769-2289-0558, 0769-22890598, QQ:2533190771 |
Description(产品描述):
Human Cytomegalovirus (AD169 strain) Quantitated Viral DNA PCR control.
For research use only. Not for use in diagnostic procedures.
ABI’s Quantitated PCR Controls can be used to generate standard curves for quantitative PCR assays and as positive controls in nucleic acid amplification reactions. Quantitated PCR Controls for viruses, bacteria, and other organisms such as Toxoplasma gondii and Mycoplasma pneumoniae are available.
ABI’s Quantitated PCR Controls are purified from one of the following sources:
- Intact Viral Particles, Parasites or Mollicutes
- Cultured Bacteria: pelleted bacteria from liquid, plate, or slant culture
- Cloned viral DNA
Quantitated PCR Controls are supplied in volumes of 250 µL at 1-2 x 104 DNA copies/µL (except for BK and JC polyomaviruses, and Porcine Circovirus Type 2 (PCV2), which are supplied at 1-2 x 105 DNA copies/µL). Quantitation with different instruments and by different methods may not give the same copy number results.
Note: ABI’s Quantitated PCR Controls are intended for use as positive PCR quantitative standards for the organism in question. Due to the nature of these products, ABI cannot guarantee their suitability as extraction controls. Additionally, due to the extreme sensitivity of detection in PCR reactions, and since no method of purification can guarantee the complete absence of extraneous agents, PCR controls are not intended for use as negative controls for other organisms.
ABI’s PCR Controls are for research use only and are not for use in diagnostic assays.
Details(注意事项):
Shipping and Storage: This product is shipped frozen on dry ice. Store at -20°C upon receipt. Avoid multiple freeze-thaw cycles as product degradation may result.
Recommendations: Upon thawing, centrifuge the vial for a few seconds to remove residual droplets from the lid.CAUTION: ABI does not recommend storage of dilutions of quantitative DNA Controls under any conditions. All dilutions should be made immediately before use and used promptly. We have observed that dilutions used for standard curves may tend to “lose” copy number with time (sometimes a matter of an hour or so after dilution), especially at dilutions less than 100-1000 copies per microliter.
Safe Handling Recommendation: The DNA extraction procedure used has been shown to eliminate the infectivity of most viruses and bacteria; therefore, this product is not considered biohazardous. However, this product is not specifically tested for infectivity and should be handled in accordance with Good Laboratory Practices and any applicable local guidelines.
FAO(常见问题):
How are Quantitated DNA controls supplied? Quantitated DNA controls are supplied at 1-2 × 104 copies/µL (with the exception of BK and JC polyomaviruses and PCV2, which are supplied at 1-2 × 105 copies/µL). The copy number of Quantitated DNA controls is determined by real-time PCR.
How can dilutions of Quantitated DNA controls be stored? ABI does not recommend storing dilutions of these controls under any conditions. All dilutions should be made immediately before use and used promptly. We have observed that dilutions used for standard curves typically “lose” copy number with time — sometimes as soon as an hour or so after dilution. This is especially common at dilutions less than 100-1000 copies per microliter.
Applications for use(适用范围):
- PCR
- Nucleic Acid-Based Assay
Quality control testing includes(质量控制检测包括):
- PCR
Certificate of Analysis(分析报告):
Reference Articles(已发表参考文献):
Yaari S, Koslowsky B, Wolf D, Chajek-Shaul T, Hershcovici T. “CMV-related thrombocytopenia treated with foscarnet: A case series and review of the literature.” Platelets. 2010;21(6):490-495.
Goegebuer T, Van Meensel B, Beuselinck K, et al. “Clinical Predictive Value of Real-Time PCR Quantification of Human Cytomegalovirus DNA in Amniotic Fluid Samples.” Journal of Clinical Microbiology. 2009;47(3):660-665.
Habbal W, Monem F, Gartner BC. “Comparative evaluation of published cytomegalovirus primers for rapid real-time PCR: which are the most sensitive?” Journal of Medical Microbiology. 2009;58(7):878-883.
Tang W, Elmore SH, Fan H, Thorne LB, Gulley ML. “Cytomegalovirus DNA Measurement in Blood and Plasma Using Roche LightCycler CMV Quantification Reagents.” Diagnostic Molecular Pathology. 2008;17(3):166-173.
Harwani SC, Lurain NS, Zariffard RM, Spear GT. “Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue.” Virology Journal. 2007;4(1):133.
Alvarez-Lafuente R, Heras VDL, Bartolome M, Garcia-Montojo M, Arroyo R. “Human Herpesvirus 6 and Multiple Sclerosis: A One-Year Follow-up Study.” Brain Pathology. 2006;16(1):20-27.
Verkruyse LA, Storch GA, Devine SM, DiPersio JF, Vij R. “Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load >e;10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients.” Bone Marrow Transplantation. 2005.
Schvoerer E, Henriot S, Zachary P, et al. “Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.” Journal of Medical Virology. 2005;76(1):76-81.
Ryan JL, Fan H, Glaser SL, Schichman SA, Raab-Traub N, Gulley ML. “Epstein-Barr Virus Quantitation by Real-Time PCR Targeting Multiple Gene Segments: A Novel Approach to Screen for the Virus in Paraffin-Embedded Tissue and Plasma.” J Mol Diagn. 2004;6:378-385.
Jebbink J, Bai X, Rogers BB, Dawson BD, Scheuermann RH, Domiati-Saad R. “Development of Real-Time PCR Assays for the Quantitative Detection of Epstein-Barr Virus and Cytomegalovirus, Comparison of TaqMan Probes, and Molecular Beacons.” J Mol Diagn. 2003;5:15-20.
Stocher M, Berg J. “Normalized Quantification of Human Cytomegalovirus DNA by Competitive Real-Time PCR on the LightCycler Instrument.” Journal of Clinical Microbiology. 2002;40(12):4547-4553.
de Jong MD, Weel JFL, Schuurman T, Dillen PW-vanME, Boom R. “Quantitation of Varicella-Zoster Virus DNA in Whole Blood, Plasma, and Serum by PCR and Electrochemiluminescence.” Journal of Clinical Microbiology. 2000;38(7).